ECHO Diabetes FQHC
Extension for Community Health Outcomes (ECHO) Diabetes Federally Qualified Health Centers (FQHCs)
1 other identifier
observational
18
1 country
2
Brief Summary
Extension for Community Health Outcomes Diabetes FQHC will provide tele-education to primary care providers (PCP) in Federally Qualified Health Centers in the U.S. using the "hub" and "spoke" training model established in the Project ECHO model. Participating FQHCs (called "spokes") will receive twice monthly tele-education sessions delivered by UF's "hub" team in a 6-month program. The program will be evaluated using pre/posttest provider-level surveys and center-level aggregate data in a stepped-wedge trial design with 3 cohorts of FQHCs. The primary outcomes are the proportion of people \>9% HbA1c and technology use (CGM and insulin pump).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2026
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 22, 2026
CompletedFirst Submitted
Initial submission to the registry
February 10, 2026
CompletedFirst Posted
Study publicly available on registry
February 18, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 31, 2028
February 18, 2026
January 1, 2026
2.5 years
February 10, 2026
February 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
HEDIS >9% HbA1c
Proportion of FQHC population with \>9% HbA1c
From baseline to 12-months following
Technology Use
CGM and Pump Use
From baseline to 12-months following
Study Arms (3)
Cohort 1
6-8 Federally Qualified Health Centers that participate in the ECHO Diabetes tele-education program for PCPs
Cohort 2
6-8 Federally Qualified Health Centers that participate in the ECHO Diabetes tele-education program for PCPs
Cohort 3
6-8 FQHCs that participate in the ECHO Diabetes tele-education program for PCPs
Interventions
All cohorts will be given the ECHO Diabetes tele-education program -- one hour sessions twice monthly for 6 months for PCP in FQHCs
Eligibility Criteria
All people 18 and older with diabetes (T1D, T2D) seen for care at participating Federally Qualified Health Centers.
You may not qualify if:
- Non FQHC, not part of HCN or AC
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Health Choice Network
Miami, Florida, 33172, United States
Alliance Chicago
Chicago, Illinois, 60654, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ashby F Walker, Ph.D.
University of Florida
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 10, 2026
First Posted
February 18, 2026
Study Start
January 22, 2026
Primary Completion (Estimated)
July 31, 2028
Study Completion (Estimated)
July 31, 2028
Last Updated
February 18, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- Upon publication of data or per request of journals via the publication process
- Access Criteria
- Any one making a reasonable request for data -- all data is aggregated and do not include PHI or identifiers
Aggregate data will be shared upon reasonable requests made to project PIs